These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 13270090)
1. Treatment of circulatory failure in cholera with plasma and plasmosan. BANERJI R Burma Med J; 1955 Oct; 3(4):18-21. PubMed ID: 13270090 [No Abstract] [Full Text] [Related]
2. [Therapy of renal insufficiency with periston and fresh plasma]. HEINEN W; LOOSEN H; HEINEN H; SCHMIDT H Med Klin; 1952 Sep; 47(39):1285-8. PubMed ID: 13001885 [No Abstract] [Full Text] [Related]
3. The use of polyvinylpyrrolidone as a plasma volume expander in preventing or combating shock. SINGLETON AO Tex Rep Biol Med; 1953; 11(1):138-43. PubMed ID: 13038721 [No Abstract] [Full Text] [Related]
4. Evaluation of plasma substitutes in wound shock: polyvinylpyrrolidone. HAYNES BW; CRAWFORD ES; MAHAFFEY JH; DE BAKEY ME Surg Forum; 1953; (38th Congress):433-40. PubMed ID: 13122477 [No Abstract] [Full Text] [Related]
5. Plasma expanders in surgical shock. WEIL PG; BALDRY RE Can Serv Med J; 1954 Dec; 10(5):293-8. PubMed ID: 13209506 [No Abstract] [Full Text] [Related]
6. Plasma expanders in surgical shock. WEIL PG; BALDRY RE Can Hosp; 1955 May; 32(5):47; passim. PubMed ID: 14379067 [No Abstract] [Full Text] [Related]
8. The use of polyvinylpyrrolidone in the management of shock-like states; report of a case. O'CONNEL CL; GREENLEE DP; HERRON FT Pa Med J; 1953 Sep; 56(9):813-4. PubMed ID: 13088238 [No Abstract] [Full Text] [Related]
9. L-noradrenalin in the treatment of circulatory collapse in cholera. LAHIRI SC; BASU SN J Indian Med Assoc; 1954 Apr; 23(7):285-8. PubMed ID: 13163421 [No Abstract] [Full Text] [Related]
11. Polyvinylpyrrolidone in the treatment of traumatic and hemorrhagic shock and severe burns. CORDICE JW; SCUDDER J N Y State J Med; 1954 Mar; 54(5):652-8. PubMed ID: 13133124 [No Abstract] [Full Text] [Related]
13. [Subtosan therapy of shock]. DE MARCHI A; BRONNIMANN R Ther Umsch; 1952 Jun; 9(3):34-8. PubMed ID: 12995333 [No Abstract] [Full Text] [Related]
14. Cholera collapse and its treatment by Knox special gelatine solution. LAHIRI SC Ind Med Gaz; 1951 Sep; 86(9):396-400. PubMed ID: 14897424 [No Abstract] [Full Text] [Related]
15. Clinical experience with plasma augmenters, dextran and PVP. WEIL PG; WEBSTER DR Surg Forum; 1953 Oct; 4():712-4. PubMed ID: 13187371 [No Abstract] [Full Text] [Related]
16. [Incorporation of physiologically-active substances into a colloidal blood plasma substitute. I. Incorporation of mescaline peptide into polyvinylpyrrolidone]. JATZKEWITZ H Hoppe Seylers Z Physiol Chem; 1954; 297(3-6):149-56. PubMed ID: 13221275 [No Abstract] [Full Text] [Related]
17. [Polyvinylpyrrolidone preparations and the prospects of their use in medicine]. Vasil'ev PS; From AA; Suzdaleva VV Probl Gematol Pereliv Krovi; 1966 Jul; 11(7):17-9. PubMed ID: 6002174 [No Abstract] [Full Text] [Related]
18. Cholera associated with acute renal failure and rhabdomyolysis: a case report. Lin MC; Fang JT; Huang CC Changgeng Yi Xue Za Zhi; 1996 Dec; 19(4):371-6. PubMed ID: 9041770 [TBL] [Abstract][Full Text] [Related]
19. [Danger to patients of therapy with colloidal plasma substitutes]. BUSCH H Ther Ggw; 1955 Sep; 94(9):324-7. PubMed ID: 13291265 [No Abstract] [Full Text] [Related]